Zealand Pharma (0NZU) Financial Statements
Zealand Pharma Financial Overview
Zealand Pharma's market cap is currently $16.68B. The company's EPS TTM is $38.98; its P/E ratio is 6.00; Zealand Pharma is scheduled to report earnings on November 12, 2026, and the estimated EPS forecast is $-10.39. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 9.21B | $ 62.69M | $ 342.79M | $ 103.99M | $ 292.57M |
| Gross Profit | $ 9.19B | $ 54.82M | $ 323.61M | $ 73.28M | $ 173.75M |
| Operating Income | $ 7.16B | $ -1.27B | $ -572.24M | $ -816.60M | $ -1.05B |
| EBITDA | $ 7.18B | $ -1.02B | $ -651.58M | $ -797.63M | $ -729.68M |
| Net Income | $ 6.46B | $ -1.08B | $ -703.74M | $ -965.61M | $ -1.02B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 15.11B | $ 8.23B | $ 1.63B | $ 1.18B | $ 1.43B |
| Total Assets | $ 16.46B | $ 9.51B | $ 1.98B | $ 1.54B | $ 2.07B |
| Total Debt | $ 405.77M | $ 391.76M | $ 119.23M | $ 443.47M | $ 787.43M |
| Net Debt | $ -4.17B | $ -88.55M | $ -330.08M | $ -625.76M | $ -341.67M |
| Total Liabilities | $ 1.63B | $ 888.86M | $ 387.15M | $ 723.89M | $ 1.14B |
| Stockholders' Equity | $ 14.83B | $ 8.62B | $ 1.59B | $ 815.91M | $ 927.80M |
| Cash Flow | |||||
| Free Cash Flow | $ 6.50B | $ -943.96M | $ -449.42M | $ -953.92M | $ -1.23B |
| Operating Cash Flow | $ 6.53B | $ -930.82M | $ -425.67M | $ -942.21M | $ -1.21B |
| Investing Cash Flow | $ -2.25B | $ -7.33B | $ -1.09B | $ 281.26M | $ -18.12M |
| Financing Cash Flow | $ -378.18M | $ 8.29B | $ 907.01M | $ 587.40M | $ 1.33B |
Currency in DKK